Achaogen, Inc. (AKAO) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:58,200100,500144,000164,800199,400230,300
Cash and cash equivalents55,63563,29194,898145,219134,657143,999
Short-term investments 2,58937,24449,10019,57264,74486,295
Other undisclosed cash, cash equivalents, and short-term investments(24)(35)29(1)6
Restricted cash and investments3285,7576,9985,8917,3808,991
Inventory, net of allowances, customer advances and progress billings637     
Inventory637     
Prepaid expense1,6822,1792,1521,7551,4901,860
Asset, held-for-sale, not part of disposal group      
Other current assets342591751295298173
Other undisclosed current assets6,3297,7797,8285,6654,6986,888
Total current assets:67,518116,806161,729178,406213,266248,212
Noncurrent Assets
Inventory, Noncurrent1,604     
Property, plant and equipment15,75420,61117,22814,81012,97211,415
Restricted cash and investments6,2671,2061,3203,8553,8553,575
Other noncurrent assets6,1584,0742,828   
Total noncurrent assets:29,78325,89121,37618,66516,82714,990
TOTAL ASSETS:97,301142,697183,105197,071230,093263,202
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25,27530,08621,52722,30315,28816,235
Accounts payable10,9206,5786,8706,8625,8207,850
Accrued liabilities14,35523,50814,65715,4419,4688,385
Debt   12,50012,50010,417
Derivative instruments and hedges, liabilities950     
Deferred revenue and credits1,5452,1002,7082,968
Other liabilities      28
Other undisclosed current liabilities 328696    
Total current liabilities:26,55330,78223,07236,90330,49629,648
Noncurrent Liabilities
Long-term debt and lease obligation 24,77324,62224,4729,45712,37415,280
Long-term debt, excluding current maturities 24,77324,62224,4729,45712,37415,280
Liabilities, other than long-term debt8,58810,90010,3078,9758,2606,718
Deferred revenue and credits9,4778,2897,5966,076
Deferred rent credit8,5889,962 
Derivative instruments and hedges, liabilities  938830686664642
Other undisclosed noncurrent liabilities2,6007,47712,1619,77415,68123,043
Total noncurrent liabilities:35,96142,99946,94028,20636,31545,041
Total liabilities:62,51473,78170,01265,10966,81174,689
Equity
Equity, attributable to parent24,78758,916103,093121,962153,282178,513
Common stock464545424242
Additional paid in capital536,569528,909523,141494,758489,704485,061
Accumulated other comprehensive loss  (2)(26) (9)(42)
Accumulated deficit(511,828)(470,036)(420,067)(372,838)(336,455)(306,548)
Other undisclosed equity 10,00010,00010,00010,000  
Total equity:34,78768,916113,093131,962153,282178,513
TOTAL LIABILITIES AND EQUITY:97,301142,697183,105197,071220,093253,202

Income Statement (P&L) ($ in thousands)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Revenues1,9982,5622,1431,8695771,266
Revenue, net 300206
Cost of revenue
(Cost of Goods and Services Sold)
(11)     
Gross profit:1,9872,5622,1431,8695771,266
Operating expenses(48,624)(57,408)(45,980)(43,973)(37,121)(31,059)
Other undisclosed operating income11     
Operating loss:(46,626)(54,846)(43,837)(42,104)(36,544)(29,793)
Nonoperating income
(Other Nonoperating income)
405596562521604221
Interest and debt expense(435)(295)(1,423)(685)(740)(723)
Loss from continuing operations:(46,656)(54,545)(44,698)(42,268)(36,680)(30,295)
Loss before gain (loss) on sale of properties:(46,656)(54,545)(44,698)(42,268)(36,680)(30,295)
Other undisclosed net loss      
Net loss:(46,656)(54,545)(44,698)(42,268)(36,680)(30,295)
Other undisclosed net income (loss) attributable to parent 4,8654,576(2,531)5,8856,7734,225
Net loss available to common stockholders, basic:(41,791)(49,969)(47,229)(36,383)(29,907)(26,070)
Other undisclosed net loss available to common stockholders, diluted(4,877)(4,684)  (6,795)(4,246)
Net loss available to common stockholders, diluted:(46,668)(54,653)(47,229)(36,383)(36,702)(30,316)

Comprehensive Income ($ in thousands)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Net loss:(46,656)(54,545)(44,698)(42,268)(36,680)(30,295)
Comprehensive loss:(46,656)(54,545)(44,698)(42,268)(36,680)(30,295)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 4,8674,600(2,557)5,8946,8064,242
Comprehensive loss, net of tax, attributable to parent:(41,789)(49,945)(47,255)(36,374)(29,874)(26,053)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: